Absci (ABSI) FCF Margin (2020 - 2026)
Absci's (ABSI) quarterly FCF Margin came in at 12249.77% in Q1 2026, down 1039531.0% year-on-year from N/an in Q1 2025, and down 173.82% quarter-over-quarter from 4473.69% in Q4 2025.
Absci (ABSI) FCF Margin (2020 - 2026) Analysis & Trends
Absci has disclosed FCF Margin across 7 years of filings, most recently posting 12249.77% for Q1 2026.
- FCF Margin for Q1 2026 came in at 12249.77%, down 1039531.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5365.2% (down 376721.0% YoY), and the FY2025 annual result was 3358.29%, down 174951.0% from the prior year.
- FCF Margin came in at 12249.77% for Q1 2026 at Absci, down from 4473.69% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 583.43% in Q2 2023 to a low of 12249.77% in Q1 2026.
- The 5-year median for FCF Margin is 2521.31% (2022), against an average of 3337.08%.
- Across the five-year window, FCF Margin surged 2070327 bps in 2022 and tumbled 1039531 bps in 2026, its largest moves.
- Absci's FCF Margin stood at 2521.31% in 2022, then slumped by 75 bps to 4419.82% in 2023, then soared by 42 bps to 2574.89% in 2024, then slumped by 74 bps to 4473.69% in 2025, then sank by 174 bps to 12249.77% in 2026.
- The last three FCF Margin figures came in at 12249.77% (Q1 2026), 4473.69% (Q4 2025), and 6876.46% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | -12,249.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,249.77% |
| Dec 31, 2025 | -4,473.69% |
| Sep 30, 2025 | -6,876.46% |
| Jun 30, 2025 | -2,882.97% |
| Mar 31, 2025 | -1,854.45% |
| Dec 31, 2024 | -2,574.89% |
| Sep 30, 2024 | -1,221.63% |
| Jun 30, 2024 | -1,352.44% |
| Mar 31, 2024 | -1,989.20% |
| Dec 31, 2023 | -4,419.82% |
| Sep 30, 2023 | -1,433.87% |
| Jun 30, 2023 | -583.43% |
| Mar 31, 2023 | -1,595.35% |
| Dec 31, 2022 | -2,521.31% |
| Sep 30, 2022 | -1,009.41% |
| Jun 30, 2022 | -2,998.20% |
| Mar 31, 2022 | -6,693.42% |
| Dec 31, 2021 | 1,043.74% |
| Sep 30, 2021 | -1,968.85% |
| Jun 30, 2021 | -23,701.47% |